Theresa Wingrove
General Counsel bij IMMUNOGEN, INC.
Profiel
Theresa G.
Wingrove is currently the Senior Vice President-Regulatory Affairs & Quality at ImmunoGen, Inc. She previously worked as the Senior Director-Clinical & Regulatory Affairs at MediSpectra, Inc. from 2000 to 2010.
She also held the position of Vice President-Clinical & Regulatory Affairs at Histogenics Corp.
from 2006 to 2011.
Dr. Wingrove has a doctorate degree from the University of Rochester and an undergraduate degree from Brown University.
Actieve functies van Theresa Wingrove
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNOGEN, INC. | General Counsel | 01-01-2011 |
Eerdere bekende functies van Theresa Wingrove
| Bedrijven | Functie | Einde |
|---|---|---|
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | 01-01-2011 |
MediSpectra, Inc.
 MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Chief Tech/Sci/R&D Officer | 26-03-2010 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Opleiding van Theresa Wingrove
| Rochester Christian University | Doctorate Degree |
| Brown University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
MediSpectra, Inc.
MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Commercial Services |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
